FRLN
$0.58
Freeline Therapeutics Holdings Plc Adss
$.00
(.67%)
FRLN
Earnings Whisper ®
N/A
4th Quarter December 2022
Consensus:  ($0.29)
Revenue:  $25.00 Mil
Tuesday
Feb 14
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when FRLN reports earnings?
Beat
Meet
Miss

Where is FRLN's stock price going from here?
Up
Flat
Down
Stock chart of FRLN
Analysts
Summary of analysts' recommendations for FRLN
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Freeline Therapeutics Holdings plc is a clinical-stage biotechnology company. It is focused on AAV-based gene therapy targeting the liver. The company operates principally in Germany and the U.S. Freeline Therapeutics Holdings plc is headquartered in the U.K.